HEADER HYDROLASE 29-JUL-08 3DZG TITLE CRYSTAL STRUCTURE OF HUMAN CD38 EXTRACELLULAR DOMAIN, ARA-F-RIBOSE-5'- TITLE 2 PHOSPHATE/NICOTINAMIDE COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADP-RIBOSYL CYCLASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: ENZYMATIC DOMAIN: UNP RESIDUES 45-300; COMPND 5 SYNONYM: CYCLIC ADP-RIBOSE HYDROLASE 1, CADPR HYDROLASE 1, T10, CD38 COMPND 6 ANTIGEN; COMPND 7 EC: 3.2.2.5; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 GENE: CD38; SOURCE 5 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: X-33 (INVITROGEN); SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PPICZ(ALPHA)A KEYWDS COVALENT INTERMEDIATE COMPLEX, NICOTINAMIDE COMPLEX, BETA SHEETS, KEYWDS 2 ALPHA BUNDLE, DIABETES MELLITUS, GLYCOPROTEIN, HYDROLASE, MEMBRANE, KEYWDS 3 NAD, RECEPTOR, SIGNAL-ANCHOR, TRANSMEMBRANE EXPDTA X-RAY DIFFRACTION AUTHOR Q.LIU,I.A.KRIKSUNOV,H.JIANG,R.GRAEFF,H.LIN,H.C.LEE,Q.HAO REVDAT 7 20-NOV-24 3DZG 1 REMARK REVDAT 6 30-AUG-23 3DZG 1 REMARK REVDAT 5 20-OCT-21 3DZG 1 SEQADV HETSYN REVDAT 4 29-JUL-20 3DZG 1 REMARK SEQADV SITE REVDAT 3 08-JUN-16 3DZG 1 HETATM VERSN REVDAT 2 24-FEB-09 3DZG 1 VERSN REVDAT 1 04-NOV-08 3DZG 0 JRNL AUTH Q.LIU,I.A.KRIKSUNOV,H.JIANG,R.GRAEFF,H.LIN,H.C.LEE,Q.HAO JRNL TITL COVALENT AND NONCOVALENT INTERMEDIATES OF AN NAD UTILIZING JRNL TITL 2 ENZYME, HUMAN CD38. JRNL REF CHEM.BIOL. V. 15 1068 2008 JRNL REFN ISSN 1074-5521 JRNL PMID 18940667 JRNL DOI 10.1016/J.CHEMBIOL.2008.08.007 REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.3.0021 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 58833 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3138 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.69 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3602 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.1790 REMARK 3 BIN FREE R VALUE SET COUNT : 177 REMARK 3 BIN FREE R VALUE : 0.2130 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4100 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 468 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.73000 REMARK 3 B22 (A**2) : 0.34000 REMARK 3 B33 (A**2) : 1.03000 REMARK 3 B12 (A**2) : 0.51000 REMARK 3 B13 (A**2) : 0.49000 REMARK 3 B23 (A**2) : 0.94000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.098 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.099 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.060 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.285 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.942 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4260 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5776 ; 1.504 ; 1.945 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 502 ; 5.853 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 208 ;37.806 ;24.038 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 742 ;15.211 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;17.600 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 618 ; 0.102 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3224 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2128 ; 0.220 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2906 ; 0.316 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 421 ; 0.160 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 64 ; 0.207 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 33 ; 0.179 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2562 ; 0.901 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4114 ; 1.483 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1913 ; 2.415 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1662 ; 3.777 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3DZG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JUL-08. REMARK 100 THE DEPOSITION ID IS D_1000048682. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-APR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : A1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9778 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 61988 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.640 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 5.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.05600 REMARK 200 R SYM (I) : 0.05600 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.64 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.18900 REMARK 200 R SYM FOR SHELL (I) : 0.18900 REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1YH3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES PH 6.0, 15% PEG 4000, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 39 REMARK 465 ARG A 40 REMARK 465 GLU A 41 REMARK 465 ALA A 42 REMARK 465 GLU A 43 REMARK 465 ALA A 44 REMARK 465 THR A 297 REMARK 465 SER A 298 REMARK 465 GLU A 299 REMARK 465 ILE A 300 REMARK 465 LYS B 39 REMARK 465 ARG B 40 REMARK 465 GLU B 41 REMARK 465 ALA B 42 REMARK 465 GLU B 43 REMARK 465 ALA B 44 REMARK 465 THR B 297 REMARK 465 SER B 298 REMARK 465 GLU B 299 REMARK 465 ILE B 300 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU B 226 C1 RF5 B 301 1.34 REMARK 500 OE2 GLU A 226 C1 RF5 A 301 1.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 72 CD GLU A 72 OE2 0.152 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL A 68 CA - CB - CG1 ANGL. DEV. = -10.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 128 53.42 -151.69 REMARK 500 GLN A 139 19.16 -151.53 REMARK 500 ASP A 164 14.18 58.92 REMARK 500 ASP A 179 -62.67 -108.69 REMARK 500 CYS A 180 145.47 -171.43 REMARK 500 ASP A 202 -121.62 60.89 REMARK 500 ARG A 247 128.99 -38.79 REMARK 500 GLU A 248 -123.53 62.38 REMARK 500 ASN A 270 35.94 73.65 REMARK 500 GLU A 292 -27.69 80.02 REMARK 500 SER A 295 42.67 -24.38 REMARK 500 SER B 95 -7.34 75.92 REMARK 500 ILE B 128 56.38 -151.82 REMARK 500 ASP B 179 -74.88 -108.84 REMARK 500 ASP B 202 -116.77 61.02 REMARK 500 GLU B 248 -172.17 59.95 REMARK 500 PRO B 291 -93.80 -16.55 REMARK 500 ASP B 293 -159.03 -83.18 REMARK 500 SER B 294 50.48 34.42 REMARK 500 SER B 295 75.85 22.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 AUTHORS STATE THAT THE LIGAND RF5 IN THIS ENTRY IS A REMARK 600 REACTION INTERMEDIATE, WITH THE (C1') ATOM HAVING SP2 REMARK 600 HYBRIDIZATION (C1'H) NOT THE SP3 HYBRIDIZATION (C1'H2). REMARK 600 AUTHORS ALSO STATE THAT THE PRESENCE OF COVALENT LINK REMARK 600 IS THE NATURE OF THE COVALENT REACTION INTERMEDIATE RF5. REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 RF5 A 301 REMARK 610 RF5 B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3DZF RELATED DB: PDB REMARK 900 HUMAN CD38 EXTRACELLULAR DOMAIN, ARA-2-DEOXY-2-FLUORO-RIBOSE-5'- REMARK 900 PHOSPHATE COMPLEX REMARK 900 RELATED ID: 3DZH RELATED DB: PDB REMARK 900 HUMAN CD38 EXTRACELLULAR DOMAIN, GTP COMPLEX REMARK 900 RELATED ID: 3DZI RELATED DB: PDB REMARK 900 HUMAN CD38 EXTRACELLULAR DOMAIN, RIBOSE-5'-PHOSPHATE INTERMEDIATE/ REMARK 900 GTP COMPLEX REMARK 900 RELATED ID: 3DZJ RELATED DB: PDB REMARK 900 HUMAN CD38 EXTRACELLULAR DOMAIN E226Q MUTANT, NMN COMPLEX REMARK 900 RELATED ID: 3DZK RELATED DB: PDB REMARK 900 HUMAN CD38 EXTRACELLULAR DOMAIN, NMN COMPLEX DBREF 3DZG A 45 300 UNP P28907 CD38_HUMAN 45 300 DBREF 3DZG B 45 300 UNP P28907 CD38_HUMAN 45 300 SEQADV 3DZG LYS A 39 UNP P28907 EXPRESSION TAG SEQADV 3DZG ARG A 40 UNP P28907 EXPRESSION TAG SEQADV 3DZG GLU A 41 UNP P28907 EXPRESSION TAG SEQADV 3DZG ALA A 42 UNP P28907 EXPRESSION TAG SEQADV 3DZG GLU A 43 UNP P28907 EXPRESSION TAG SEQADV 3DZG ALA A 44 UNP P28907 EXPRESSION TAG SEQADV 3DZG THR A 49 UNP P28907 GLN 49 ENGINEERED MUTATION SEQADV 3DZG ASP A 100 UNP P28907 ASN 100 ENGINEERED MUTATION SEQADV 3DZG ASP A 164 UNP P28907 ASN 164 ENGINEERED MUTATION SEQADV 3DZG ASP A 209 UNP P28907 ASN 209 ENGINEERED MUTATION SEQADV 3DZG ASP A 219 UNP P28907 ASN 219 ENGINEERED MUTATION SEQADV 3DZG LYS B 39 UNP P28907 EXPRESSION TAG SEQADV 3DZG ARG B 40 UNP P28907 EXPRESSION TAG SEQADV 3DZG GLU B 41 UNP P28907 EXPRESSION TAG SEQADV 3DZG ALA B 42 UNP P28907 EXPRESSION TAG SEQADV 3DZG GLU B 43 UNP P28907 EXPRESSION TAG SEQADV 3DZG ALA B 44 UNP P28907 EXPRESSION TAG SEQADV 3DZG THR B 49 UNP P28907 GLN 49 ENGINEERED MUTATION SEQADV 3DZG ASP B 100 UNP P28907 ASN 100 ENGINEERED MUTATION SEQADV 3DZG ASP B 164 UNP P28907 ASN 164 ENGINEERED MUTATION SEQADV 3DZG ASP B 209 UNP P28907 ASN 209 ENGINEERED MUTATION SEQADV 3DZG ASP B 219 UNP P28907 ASN 219 ENGINEERED MUTATION SEQRES 1 A 262 LYS ARG GLU ALA GLU ALA ARG TRP ARG GLN THR TRP SER SEQRES 2 A 262 GLY PRO GLY THR THR LYS ARG PHE PRO GLU THR VAL LEU SEQRES 3 A 262 ALA ARG CYS VAL LYS TYR THR GLU ILE HIS PRO GLU MET SEQRES 4 A 262 ARG HIS VAL ASP CYS GLN SER VAL TRP ASP ALA PHE LYS SEQRES 5 A 262 GLY ALA PHE ILE SER LYS HIS PRO CYS ASP ILE THR GLU SEQRES 6 A 262 GLU ASP TYR GLN PRO LEU MET LYS LEU GLY THR GLN THR SEQRES 7 A 262 VAL PRO CYS ASN LYS ILE LEU LEU TRP SER ARG ILE LYS SEQRES 8 A 262 ASP LEU ALA HIS GLN PHE THR GLN VAL GLN ARG ASP MET SEQRES 9 A 262 PHE THR LEU GLU ASP THR LEU LEU GLY TYR LEU ALA ASP SEQRES 10 A 262 ASP LEU THR TRP CYS GLY GLU PHE ASP THR SER LYS ILE SEQRES 11 A 262 ASN TYR GLN SER CYS PRO ASP TRP ARG LYS ASP CYS SER SEQRES 12 A 262 ASN ASN PRO VAL SER VAL PHE TRP LYS THR VAL SER ARG SEQRES 13 A 262 ARG PHE ALA GLU ALA ALA CYS ASP VAL VAL HIS VAL MET SEQRES 14 A 262 LEU ASP GLY SER ARG SER LYS ILE PHE ASP LYS ASP SER SEQRES 15 A 262 THR PHE GLY SER VAL GLU VAL HIS ASN LEU GLN PRO GLU SEQRES 16 A 262 LYS VAL GLN THR LEU GLU ALA TRP VAL ILE HIS GLY GLY SEQRES 17 A 262 ARG GLU ASP SER ARG ASP LEU CYS GLN ASP PRO THR ILE SEQRES 18 A 262 LYS GLU LEU GLU SER ILE ILE SER LYS ARG ASN ILE GLN SEQRES 19 A 262 PHE SER CYS LYS ASN ILE TYR ARG PRO ASP LYS PHE LEU SEQRES 20 A 262 GLN CYS VAL LYS ASN PRO GLU ASP SER SER CYS THR SER SEQRES 21 A 262 GLU ILE SEQRES 1 B 262 LYS ARG GLU ALA GLU ALA ARG TRP ARG GLN THR TRP SER SEQRES 2 B 262 GLY PRO GLY THR THR LYS ARG PHE PRO GLU THR VAL LEU SEQRES 3 B 262 ALA ARG CYS VAL LYS TYR THR GLU ILE HIS PRO GLU MET SEQRES 4 B 262 ARG HIS VAL ASP CYS GLN SER VAL TRP ASP ALA PHE LYS SEQRES 5 B 262 GLY ALA PHE ILE SER LYS HIS PRO CYS ASP ILE THR GLU SEQRES 6 B 262 GLU ASP TYR GLN PRO LEU MET LYS LEU GLY THR GLN THR SEQRES 7 B 262 VAL PRO CYS ASN LYS ILE LEU LEU TRP SER ARG ILE LYS SEQRES 8 B 262 ASP LEU ALA HIS GLN PHE THR GLN VAL GLN ARG ASP MET SEQRES 9 B 262 PHE THR LEU GLU ASP THR LEU LEU GLY TYR LEU ALA ASP SEQRES 10 B 262 ASP LEU THR TRP CYS GLY GLU PHE ASP THR SER LYS ILE SEQRES 11 B 262 ASN TYR GLN SER CYS PRO ASP TRP ARG LYS ASP CYS SER SEQRES 12 B 262 ASN ASN PRO VAL SER VAL PHE TRP LYS THR VAL SER ARG SEQRES 13 B 262 ARG PHE ALA GLU ALA ALA CYS ASP VAL VAL HIS VAL MET SEQRES 14 B 262 LEU ASP GLY SER ARG SER LYS ILE PHE ASP LYS ASP SER SEQRES 15 B 262 THR PHE GLY SER VAL GLU VAL HIS ASN LEU GLN PRO GLU SEQRES 16 B 262 LYS VAL GLN THR LEU GLU ALA TRP VAL ILE HIS GLY GLY SEQRES 17 B 262 ARG GLU ASP SER ARG ASP LEU CYS GLN ASP PRO THR ILE SEQRES 18 B 262 LYS GLU LEU GLU SER ILE ILE SER LYS ARG ASN ILE GLN SEQRES 19 B 262 PHE SER CYS LYS ASN ILE TYR ARG PRO ASP LYS PHE LEU SEQRES 20 B 262 GLN CYS VAL LYS ASN PRO GLU ASP SER SER CYS THR SER SEQRES 21 B 262 GLU ILE HET RF5 A 301 13 HET NCA A 302 9 HET RF5 B 301 13 HET NCA B 302 9 HETNAM RF5 2-DEOXY-2-FLUORO-5-O-PHOSPHONO-ALPHA-D-ARABINOFURANOSE HETNAM NCA NICOTINAMIDE HETSYN RF5 INHIBITOR ARABINOSYL-2-FLUORO-2-DEOXYNICOTINAMIDE HETSYN 2 RF5 MONONUCLEOTIDE, BOUND FORM; 2-DEOXY-2-FLUORO-5-O- HETSYN 3 RF5 PHOSPHONO-ALPHA-D-ARABINOSE; 2-DEOXY-2-FLUORO-5-O- HETSYN 4 RF5 PHOSPHONO-D-ARABINOSE; 2-DEOXY-2-FLUORO-5-O-PHOSPHONO- HETSYN 5 RF5 ARABINOSE FORMUL 3 RF5 2(C5 H10 F O7 P) FORMUL 4 NCA 2(C6 H6 N2 O) FORMUL 7 HOH *468(H2 O) HELIX 1 1 ARG A 58 HIS A 74 1 17 HELIX 2 2 PRO A 75 ARG A 78 5 4 HELIX 3 3 ASP A 81 ILE A 94 1 14 HELIX 4 4 THR A 102 ASP A 105 5 4 HELIX 5 5 TYR A 106 GLY A 113 1 8 HELIX 6 6 PRO A 118 LYS A 121 5 4 HELIX 7 7 ILE A 128 VAL A 138 1 11 HELIX 8 8 THR A 144 ASP A 147 5 4 HELIX 9 9 THR A 148 ASP A 155 1 8 HELIX 10 10 ASN A 183 ALA A 200 1 18 HELIX 11 11 SER A 220 VAL A 225 1 6 HELIX 12 12 VAL A 225 LEU A 230 1 6 HELIX 13 13 ASP A 252 GLN A 255 5 4 HELIX 14 14 ASP A 256 ARG A 269 1 14 HELIX 15 15 ARG A 280 ASN A 290 1 11 HELIX 16 16 ARG B 58 HIS B 74 1 17 HELIX 17 17 PRO B 75 ARG B 78 5 4 HELIX 18 18 ASP B 81 ILE B 94 1 14 HELIX 19 19 THR B 102 ASP B 105 5 4 HELIX 20 20 TYR B 106 GLY B 113 1 8 HELIX 21 21 ILE B 128 GLN B 139 1 12 HELIX 22 22 THR B 144 ASP B 147 5 4 HELIX 23 23 THR B 148 ASP B 155 1 8 HELIX 24 24 ASN B 183 ALA B 200 1 18 HELIX 25 25 SER B 220 VAL B 225 1 6 HELIX 26 26 GLU B 226 LEU B 230 5 5 HELIX 27 27 ASP B 252 GLN B 255 5 4 HELIX 28 28 ASP B 256 ARG B 269 1 14 HELIX 29 29 ARG B 280 ASN B 290 1 11 SHEET 1 A 2 GLY A 52 PRO A 53 0 SHEET 2 A 2 SER A 172 CYS A 173 -1 O CYS A 173 N GLY A 52 SHEET 1 B 4 LEU A 123 SER A 126 0 SHEET 2 B 4 ASP A 202 ASP A 209 1 O HIS A 205 N LEU A 124 SHEET 3 B 4 VAL A 235 ILE A 243 1 O TRP A 241 N VAL A 206 SHEET 4 B 4 GLN A 272 ILE A 278 1 O LYS A 276 N VAL A 242 SHEET 1 C 2 GLY A 161 GLU A 162 0 SHEET 2 C 2 THR A 165 ILE A 168 -1 O THR A 165 N GLU A 162 SHEET 1 D 2 GLY B 52 PRO B 53 0 SHEET 2 D 2 SER B 172 CYS B 173 -1 O CYS B 173 N GLY B 52 SHEET 1 E 4 LEU B 123 SER B 126 0 SHEET 2 E 4 ASP B 202 ASP B 209 1 O HIS B 205 N LEU B 124 SHEET 3 E 4 VAL B 235 ILE B 243 1 O TRP B 241 N VAL B 206 SHEET 4 E 4 GLN B 272 ILE B 278 1 O GLN B 272 N GLN B 236 SSBOND 1 CYS A 67 CYS A 82 1555 1555 2.08 SSBOND 2 CYS A 99 CYS A 180 1555 1555 2.07 SSBOND 3 CYS A 119 CYS A 201 1555 1555 2.05 SSBOND 4 CYS A 160 CYS A 173 1555 1555 2.08 SSBOND 5 CYS A 254 CYS A 275 1555 1555 2.12 SSBOND 6 CYS A 287 CYS A 296 1555 1555 2.03 SSBOND 7 CYS B 67 CYS B 82 1555 1555 2.10 SSBOND 8 CYS B 99 CYS B 180 1555 1555 2.10 SSBOND 9 CYS B 119 CYS B 201 1555 1555 2.04 SSBOND 10 CYS B 160 CYS B 173 1555 1555 2.11 SSBOND 11 CYS B 254 CYS B 275 1555 1555 2.05 SSBOND 12 CYS B 287 CYS B 296 1555 1555 2.04 CRYST1 41.689 52.812 65.381 106.06 91.95 95.12 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023987 0.002149 0.001481 0.00000 SCALE2 0.000000 0.019011 0.005564 0.00000 SCALE3 0.000000 0.000000 0.015946 0.00000